Expression of eotaxin by human lung epithelial cells. Induction by cytokines and inhibition by glucocorticoids

Journal of Clinical Investigation

Volumn 99, Issue 7, 1997, Pages 1767-1773

  Lilly, Craig M ^a   Nakamura, Hidetoshi ^a   Kesselman, Howard ^b   Nagler Anderson, Cathryn ^b   Asano, Koichiro ^a   Garcia Zepeda, Eduardo A ^b   Rothenberg, Marc E ^b   Drazen, Jeffery M ^a   Luster, Andrew D ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

allergic disease; asthma; chemokine; cytokine; eosinophil

Indexed keywords

ACETPHENOLISATIN; CHEMOKINE; CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID;

ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CALCIUM TRANSPORT; CHEMOTAXIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; LUNG LAVAGE; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; RESPIRATORY EPITHELIUM;

EID: 0030942468     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119341     Document Type: Article

References (42)

1. Kay, A.B. 1991. Asthma and inflammation. J. Allergy Clin. Immunol. 87: 893-910.
2. Mcfadden, E.R., and I.A. Gilbert. 1992. Medical progress - asthma. N. Engl. J. Med. 327:1928-1937.
3. Dunnill, M.S. 1960. The pathology of asthma, with special reference to changes in the bronchial mucosa. J. Clin. Pathol. 13:27-33.
4. Beasley, R., W.R. Roche, J.A. Roberts, and S.T. Holgate. 1989. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am. Rev. Respir. Dis. 139:806-817.
5. Laitinen, L.A., M. Heino, A. Laitinen, T. Kava, and T. Haahtela. 1985. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am. Rev. Respir. Dis. 131:599-606.
6. Bousquet, J., P. Chanez, J.Y. Lacoste, G. Barneon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Simony-Lafontaine, P. Godard, et al. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033-1039.
7. Adelroth, E., L. Rosenhall, S.A. Johansson, M. Linden, and P. Venge. 1990. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. Am. Rev. Respir. Dis. 142:91-99.
8. Burke, C., C.K. Power, A. Norris, A. Condez, B. Schmekel, and L.W. Poulter. 1992. Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma. Eur. Respir. J. 5:73-79.
9. Djukanovic, R., J.W. Wilson, K.M. Britten, S.J. Wilson, A.F. Walls, W.R. Roche, P.H. Howarth, and S.T. Holgate. 1992. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am. Rev. Respir. Dis. 145:669-674.
10. Laitinen, L.A., A. Laitinen, and T. Haahtela. 1992. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J. Allergy Clin. Immunol. 90:32-42.
11. Resnick, M.B., and P.F. Weller. 1993. Mechanisms of eosinophil recruitment. Am. J. Respir. Cell Mol. Biol. 8:349-355.
12. Mauser, P.J., A. Pitman, A. Witt, X. Fernandez, J. Zurcher, T. Kung, H. Jones, A.S. Watnick, R.W. Egan, W. Kreutner, et al. 1993. Inhibitory effect of the Trfk-5 anti-IL-5 antibody in a guinea pig model of asthma. Am. Rev. Respir. Dis. 148:1623-1627.
13. Foster, P.S., S.P. Hogan, A.J. Ramsay, K.I. Matthaei, and I.G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195-201.
14. Mauser, P.J., A.M. Pitman, X. Fernandez, S.K. Foran, G.K. Adams, W. Kreutner, R.W. Egan, and R.W. Chapman. 1995. Effects of an antibody to IL-5 in a monkey model of asthma. Am. J. Respir. Crit. Care Med. 152:467-472.
15. Jose, P.J., D.A. Griffiths-Johnson, P.D. Collins, D.T. Walsh, R. Moqbel, N.F. Totty, O. Truong, J.J. Hsuan, and T.J. Williams. 1994. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 179:881-887.
16. Rothenberg, M.E., A.D. Luster, and P. Leder. 1995. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc. Natl. Acad. Sci. USA. 92:8960-8964.
17. Rothenberg, M.E., R. Ownbey, P.D. Melhop, P.M. Loiselle, M. van de Rijn, J.V. Bonventre, H.C. Oettgen, P. Leder, and A.D. Luster. 1996. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol. Med. 2:334-348.
18. Gonzalo, J.-A., G.-Q. Jia, V. Aguirre, D. Freind, A.J. Coyle, N.A. Jenkins, G.-S. Lin, H. Katz, A. Lichtman, N. Copeland, et al. 1996. Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. Immunity. 4:1-14.
19. Garcia-Zepeda, E.A., M.E. Rothenberg, R.T. Ownbey, J. Celestin, P. Leder, and A.D. Luster. 1996. Human eotaxin is an eosinophil selective chemoattractant that provides a new mechanism to explain tissue eosinophilia. Nat. Med. 2:449-456.
20. Ponath, P.D., S. Qin, D.J. Ringler, I. Clark-Lewis, J. Wang, N. Kassam, H. Smith, X. Shi, J.-A. Gonzalo, W. Newman, et al. 1996. Cloning of the human eosinophil chemoattractant, eotaxin. J. Clin. Invest. 97:604-612.
21. Griffiths-Johnson, D.A., P.D. Collins, A.G. Rossi, P.J. Jose, and T.J. Williams. 1993. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem. Biophys. Res. Commun. 197:1167-1172.
22. Rothenberg, M.E., A.D. Luster, C.M. Lilly, J.M. Drazen, and P. Leder. 1995. Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung. J. Exp. Med. 181:1211-1216.
23. Churchill, L., F.H. Chilton, J.H. Resau, R. Bascom, W.C. Hubbard, and D. Proud. 1989. Cyclooxygenase metabolism of endogenous arachidonic acid by cultured human tracheal epithelial cells. Am. Rev. Respir. Dis. 140:449-459.
24. Holtzman, M.J., B. Ferdman, A. Bohrer, and J. Turk. 1991. Synthesis of the 1-O-Hexadecyl molecular species of platelet-activating factor by airway epithelial and vascular endothelial cells. Biochem. Biophys. Res. Commun. 177: 357-364.
25. Churchill, L., B. Friedman, R.P. Schleimer, and D. Proud. 1992. Production of granulocyte-macrophage colony-stimulating factor by cultured human tracheal epithelial cells. Immunology. 75:189-195.
26. Marini, M., E. Vittori, J. Hollemborg, and S. Mattoli. 1992. Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J. Allergy Clin. Immunol. 89:1001-1009.
27. Kwon, O.J., B.T. Au, P.D. Collins, J.N. Baraniuk, I.M. Adcock, K.F. Chung, and P.J. Barnes. 1994. Inhibition of interleukin-8 expression by dexamethasone in human cultured airway epithelial cells. Immunology. 81:389-394.
28. Sousa, A.R., S.J. Lane, J.A. Nakhosteen, T. Yoshimura, T.H. Lee, and R.N. Poston. 1994. Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects. Am. J. Respir. Cell Mol. Biol. 10:142-147.
29. Stellato, C., L.A. Beck, G.A. Gorgone, D. Proud, T.J. Schall, S.J. Ono, L.M. Lichtenstein, and R.P. Schleimer. 1995. Expression of the chemokine RANTES by a human bronchial epithelial cell line. Modulation by cytokines and glucocorticoids. J. Immunol. 155:410-418.
30. Kraft, M., R. Djukanovic, J. Torvik, L. Cunningham, J. Henson, S. Wilson, S.T. Holgate, D. Hyde, and R. Martin. 1995. Evaluation of airway inflammation by endobronchial and transbronchial biopsy in nocturnal and nonnocturnal asthma. Chest. 107(Suppl. 3):162s.
31. Borish, L., J.J. Mascali, J. Dishuck, W.R. Beam, R.J. Martin, and L.J. Rosenwasser. 1992. Detection of alveolar macrophage-derived IL-1 beta in asthma. Inhibition with corticosteroids. J. Immunol. 149:3078-3082.
32. Shaver, J.R., J.J. O'Connor, M. Pollice, S.K. Cho, G.C. Kane, J.E. Fish, and S.P. Peters. 1995. Pulmonary inflammation after segmental ragweed challenge in allergic asthmatic and nonasthmatic subjects. Am. J. Respir. Crit. Care Med. 152:1189-1197.
33. Metzger, W.J., D. Zavala, H.B. Richerson, P. Moseley, P. Iwamota, M. Monick, K. Sjoerdsma, and G.W. Hunninghake. 1987. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Description of the model and local airway inflammation. Am. Rev. Respir. Dis. 135:433-440.
34. Kwon, O.J., P.J. Jose, R.A. Robbins, T.J. Schall, T.J. Williams, and P.J. Barnes. 1995. Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. Am. J. Respir. Cell Mol. Biol. 12:488-496.
35. Caput, D., B. Beutler, K. Hartog, R. Thayer, S. Brown-Shimer, and A. Cerami. 1986. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA. 83:1670-1674.
36. Kruys, V., O. Marinx, G. Shaw, J. Deschamps, and G. Huez. 1989. Translational blockade imposed by cytokine-derived UA-rich sequences. Science (Wash. DC). 245:852-855.
37. Schleimer, R.P., and B.S. Bochner. 1994. The effects of glucocorticoids on human eosinophils. J. Allergy Clin. Immunol. 94:1202-1213.
38. Rolfe, F.G., J.M. Hughes, C.L. Armour, and W.A. Sewell. 1992. Inhibition of interleukin-5 gene expression by dexamethasone. Immunology. 77:494-499.
39. Guyre, P.M., MT. Girard, P.M. Morganelli, and P.D. Manganiello. 1988. Glucocorticoid effects on the production and actions of immune cytokines. J. Steroid Biochem. 30:89-93.
40. Wu, C.Y., C. Fargeas, T. Nakajima, and G. Delespesse. 1991. Glucocorticoids suppress the production of interleukin 4 by human lymphocytes. Eur. J. Immunol. 21:2645-2647.
41. Mukaida, N., M. Monta, Y. Ishikawa, N. Rice, S. Okamoto, T. Kasahara, and K. Matsushima. 1994. Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J. Biol. Chem. 269:13289-13295.
42. Peppel, K., J.M. Vinci, and C. Baglioni. 1991. The AU-rich sequences in the 3′ untranslated region mediate the increased turnover of interferon mRNA induced by glucocorticoids. J. Exp. Med. 173:349-355.